Duopharma Biotech Berhad (7148.KL)
- Previous Close
1.1800 - Open
1.1700 - Bid 1.1700 x --
- Ask 1.1700 x --
- Day's Range
1.1600 - 1.1800 - 52 Week Range
1.1100 - 1.5300 - Volume
56,600 - Avg. Volume
346,240 - Market Cap (intraday)
1.125B - Beta (5Y Monthly) 0.60
- PE Ratio (TTM)
19.50 - EPS (TTM)
0.0600 - Earnings Date May 20, 2024 - May 24, 2024
- Forward Dividend & Yield 0.02 (1.93%)
- Ex-Dividend Date Mar 7, 2024
- 1y Target Est
1.48
Duopharma Biotech Berhad, an investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally. The company offers consumer healthcare products comprising vitamins and supplements, analgesics, eyecare, antacids, and skin care products; and generic drugs for various therapeutic classes, such as cardiovascular, dermatology, hormones, respiratory, sensory and nervous system, musculo-skeletal system, anti-infectives, and others. It also provides specialty pharmaceutical drugs for targeted conditions, biosimilar products, and medical devices and consumables to patients with conditions, such as diabetes, cancer, cardiovascular diseases, renal diseases, and others. The company's product portfolio comprises vascor, acetan, covasc, crystorvas, bezartan, vytan, and vytocor; insugen and basalog one; kytron, zuhera, lebreta, trevive, and krabeva; and unihepa, ranofer, erysaa, bi-haemosol, and haemosol. The company offers its products under the Champs, Flavettes, Eye Glo, Proviton, Naturalle, and Uphamol brands. In addition, it offers property management and services; and distributes, imports, and exports chemical products. The company was formerly known as CCM Duopharma Biotech Berhad and changed its name to Duopharma Biotech Berhad in February 2019. The company was founded in 1978 and is headquartered in Kuala Lumpur, Malaysia.
duopharmabiotech.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Related News
Performance Overview: 7148.KL
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 7148.KL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 7148.KL
Valuation Measures
Market Cap
1.14B
Enterprise Value
1.44B
Trailing P/E
18.41
Forward P/E
16.16
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.64
Price/Book (mrq)
1.68
Enterprise Value/Revenue
2.09
Enterprise Value/EBITDA
11.47
Financial Highlights
Profitability and Income Statement
Profit Margin
7.47%
Return on Assets (ttm)
3.83%
Return on Equity (ttm)
7.84%
Revenue (ttm)
704.73M
Net Income Avi to Common (ttm)
52.65M
Diluted EPS (ttm)
0.0600
Balance Sheet and Cash Flow
Total Cash (mrq)
270.5M
Total Debt/Equity (mrq)
79.80%
Levered Free Cash Flow (ttm)
-9.42M
Research Analysis: 7148.KL
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: 7148.KL
7148.KL does not have Company Insights